Lawmakers question FTC's actions in Watson pharma investigation

Lawmakers this week questioned US Federal Trade Commission Chairman Jon Leibowitz over accusations that the commission committed misconduct in the course of a reverse payment settlement pharmaceutical investigation.

Purchase an approved for publication custom PDF below.

An official PDF provides excellent marketing opportunities, enabling you to post the article online, make reprints and distribute under the GCR brand.

• £100 (GBP)
Add Amount: 1 2 3 4 5 6 7 8 9 10
• Add to Basket